Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

530 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Gene aberrations for precision medicine against lung adenocarcinoma.
Saito M, Shiraishi K, Kunitoh H, Takenoshita S, Yokota J, Kohno T. Saito M, et al. Among authors: yokota j. Cancer Sci. 2016 Jun;107(6):713-20. doi: 10.1111/cas.12941. Epub 2016 May 25. Cancer Sci. 2016. PMID: 27027665 Free PMC article. Review.
Frequent EGFR mutations in brain metastases of lung adenocarcinoma.
Matsumoto S, Takahashi K, Iwakawa R, Matsuno Y, Nakanishi Y, Kohno T, Shimizu E, Yokota J. Matsumoto S, et al. Among authors: yokota j. Int J Cancer. 2006 Sep 15;119(6):1491-4. doi: 10.1002/ijc.21940. Int J Cancer. 2006. PMID: 16642476 Free article.
Association of the OGG1-Ser326Cys polymorphism with lung adenocarcinoma risk.
Kohno T, Kunitoh H, Toyama K, Yamamoto S, Kuchiba A, Saito D, Yanagitani N, Ishihara S, Saito R, Yokota J. Kohno T, et al. Among authors: yokota j. Cancer Sci. 2006 Aug;97(8):724-8. doi: 10.1111/j.1349-7006.2006.00240.x. Epub 2006 Jun 23. Cancer Sci. 2006. PMID: 16800823 Free article.
Identification of genes upregulated in ALK-positive and EGFR/KRAS/ALK-negative lung adenocarcinomas.
Okayama H, Kohno T, Ishii Y, Shimada Y, Shiraishi K, Iwakawa R, Furuta K, Tsuta K, Shibata T, Yamamoto S, Watanabe S, Sakamoto H, Kumamoto K, Takenoshita S, Gotoh N, Mizuno H, Sarai A, Kawano S, Yamaguchi R, Miyano S, Yokota J. Okayama H, et al. Among authors: yokota j. Cancer Res. 2012 Jan 1;72(1):100-11. doi: 10.1158/0008-5472.CAN-11-1403. Epub 2011 Nov 11. Cancer Res. 2012. PMID: 22080568
Druggable oncogene fusions in invasive mucinous lung adenocarcinoma.
Nakaoku T, Tsuta K, Ichikawa H, Shiraishi K, Sakamoto H, Enari M, Furuta K, Shimada Y, Ogiwara H, Watanabe S, Nokihara H, Yasuda K, Hiramoto M, Nammo T, Ishigame T, Schetter AJ, Okayama H, Harris CC, Kim YH, Mishima M, Yokota J, Yoshida T, Kohno T. Nakaoku T, et al. Among authors: yokota j. Clin Cancer Res. 2014 Jun 15;20(12):3087-93. doi: 10.1158/1078-0432.CCR-14-0107. Epub 2014 Apr 11. Clin Cancer Res. 2014. PMID: 24727320 Free PMC article.
A three-microRNA signature predicts responses to platinum-based doublet chemotherapy in patients with lung adenocarcinoma.
Saito M, Shiraishi K, Matsumoto K, Schetter AJ, Ogata-Kawata H, Tsuchiya N, Kunitoh H, Nokihara H, Watanabe S, Tsuta K, Kumamoto K, Takenoshita S, Yokota J, Harris CC, Kohno T. Saito M, et al. Among authors: yokota j. Clin Cancer Res. 2014 Sep 15;20(18):4784-93. doi: 10.1158/1078-0432.CCR-14-1096. Epub 2014 Aug 20. Clin Cancer Res. 2014. PMID: 25142144 Free PMC article.
530 results